VC Investment Agreements for BioMedTech Entrepreneurs

Updated: April 2024 Reading Time: 2 minutes

fsLAW, in collaboration with co11ab is co-running a panel discussion on VC Investment Agreements for BioMedTech Entrepreneurs.

During this session, we will delve into the important structures of venture capital related agreements, explore investors’ and founders’ perspectives in the biotech and medtech space.

Event details:

  • Thursday, 16 May 2024, 4:30 PM – 6:30 PM (Singapore time)
  • co11ab, Level 16, Clinical Sciences Building, 11 Mandalay Road, Singapore 308232



  • A/Prof Yen Choo – Executive Director, co11ab
  • Jason Ng – Legal Lead, ClavystBio
  • Dr Srinivas Bhylahalli – Founder, Trisail Medical and Intellimed Healthcare
  • Dr Cairan He – Director of Investor Relations & Partnership, VentureBlick



  • Faith Sing – Managing Director, fsLAW


Don’t miss this opportunity to gain valuable insights from industry leaders and engage in meaningful discussions! Please stay to say “hi” at the end during our networking session.

You can read more about our distinguished speakers and register your interest here.

More about VIMA

We will be focusing on Singapore’s Venture Capital Investment Model Agreements (VIMA) Pre-Series A suite of documents.

VIMA is a suite of model contracts available, without charge, to help start-ups in their earlier rounds of fundraising. Launched by the Singapore Academy of Law and the Singapore Venture & Private Capital Association, the documents support the Singapore Government’s endeavours to boost Singapore’s appeal as a regional hub for start-up’s and venture capital investments.

VIMA agreements aim to set out solutions to address common problems faced by entrepreneurs in similar situations.

More about shareholders’ agreements

Read more about our thoughts on shareholders’ agreements here:


Business law solutions from set-up to growth

Get in Touch with Us